JANSSEN PHARMACEUTICA NV
- Country
- Belgium
- Type
- Beneficiary
- Website
- www.janssenpharmaceutica.be
- Grants received
- 108
Funding record
- 108 grants on record
- €11,020,828.99 awarded in total
- 2008–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
78 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- BAYER AKTIENGESELLSCHAFT
- NOVARTIS PHARMA AG
- ASTRAZENECA AB
- ELI LILLY AND COMPANY LTD
- KATHOLIEKE UNIVERSITEIT LEUVEN
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Calls from this organisation
No published calls from this organisation.
Grants received
- Improving Drug Efficacy with next-generation AmorphouS materials and trained experts
- Driving Sustainable Innovation to Minimise PFAS in European Healthcare
- FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
- MedTechLabel: UNIFIED DIGITAL LABELLING FOR MEDICAL TECHNOLOGY PRODUCTS
- Ultrahigh-throughput exploration of metagenomic sequence space to discover and engineer novel biocatalysts and bioactive compounds
- Breakthrough Regulatory Innovation and Development throuGh sandbox Environments
- Research in Europe and Diversity Inclusion
- Crystallisation towards efficient and sustainable biomanufacturing
- Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
- Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
- Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- IMAGING FOR PATIENT BENEFIT IN ARTHRITIS
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
- Ion Mobility Mass Spectrometry Training Network
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.